Our Missouri benicar lawyers are accepting client who suffered gastrointestinal injury after using Benicar (also known as olmesartan medixomil).
Benicar is a drug used for the treatment of high blood pressure. It is a very common drug and it is estimated Benicar and similar drugs are used by approximately 69 million Americans. Unfortunately, it has come to light that Benicar may be unsafe because it has been linked to severe gastrointestinal problems. If you or a loved took Benicar and now suffer from gastrointestinal problems, it is important to speak with one of our Benicar lawyers today for a free legal consultation. You could be entitled to receive compensation for your injuries which could include reimbursement for medical expenses, time missed from work, pain and suffering.
Benicar was approved for use in 2002, and is manufactured by Daiichi Sankyo. It was created as a blood pressure medication, and works by keeping the body’s blood vessels dilated. It is known as an amgiotensin 2 receptor or ARB. When this hormone is suppressed, the body’s blood vessels dilate, which bring down blood pressure. Since it was released to the public, it has been linked to serious gastrointestinal conditions including sprue-like enteropathy, and villous atrophy.
The most common side effects from Benicar are:
According to a 2012 study by the Mayo Clinic, 22 patients who took Benicar experienced symptoms similar to celiac disease. The American College of Gastroenterology also reported approximately 40 more cases that same year.
In 2013, the Food and Drug Administration ordered that appropriate warnings be added to the label, stating the apparent connection between the use of Benicar and sprue-like enteropathy. The FDA reported that they were continuing to evaluate the safety of the drug. They stated there was “clear evidence of an association between Olmesartan and sprue-like enteropathy.”
The symptoms of sprue like enteropathy also closely mimic celiac disease. Unfortunately, many patients who suffer from this disorder appear to be left with permanent gastrointestinal damage. Symptoms of this disorder include:
Sprue-like enteropathy also causes problems with the body’s immune system. Often these symptoms resolve when the medication is stopped, but some patients experience permanent damage. The condition they are left with is called villious atrophy. Due to the damage to the villi of the small intestine, there is an inability to properly absorb nutrients. This causes chronic dehydration, a weakened immune system and electrolyte imbalances. Diagnosis of this condition can be difficult and often involves an endoscopy with a biopsy.
The first Benicar lawsuits were filed in 2014 and the number of cases filed continues to increase. These cases allege the manufacturer (Daiichi Sankyo) failed to adequately research and warn consumers on the potential side effects of the medication.
In April of 2015, the Benicar cases were consolidated and centralized in New Jersey Federal Court.
It is important to be aware that in every state, there is a statute of limitations, or time deadlines within which you are able to file a claim. If a claim is not filed against the manufacturer, health care provider and/or retailer before the statute expires, the injured party is permanently barred from filing a claim. If you believe you may have a claim against the manufacturers of Benicar, it is important to speak with a lawyer from our team as soon as possible.
If any cases settle, the money judgement will be based on what a jury would have awarded if the case had gone to trial, factors to be considered include:
If you took Benicar and now have gastrointestinal issues, it is important to take prompt action. Contact the Benicar lawyers at The Bradley Law Firm to learn what legal options may be available to you.